Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.51 |
| ▸ | CA12 | O43570 | 5/20 | 0.51 |
| ▸ | CA1 | P00915 | 5/20 | 0.51 |
| ▸ | CA4 | P22748 | 5/20 | 0.51 |
| ▸ | CA5A | P35218 | 5/20 | 0.51 |
| ▸ | CA7 | P43166 | 5/20 | 0.51 |
| ▸ | CA9 | Q16790 | 5/20 | 0.51 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11348721 | 0.88 | CA2 (0.60) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL500627 | 0.87 | MEN1 (0.71) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL27850950 | 0.82 | CA2 (0.55) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL18261812 | 0.82 | MEN1 (0.65) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL28254358 | 0.80 | MEN1 (0.62) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL10938237 | 0.80 | CA2 (0.50) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL11769412 | 0.79 | MEN1 (0.45) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL7482409 | 0.79 | CA2 (0.49) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL18261830 | 0.78 | MEN1 (0.65) | MEN1KMT2ACA2CA12CA1 | |
| SCHEMBL11774069 | 0.78 | CA2 (0.43) | MEN1KMT2ACA2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250024840-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | UNITED INDUSTRIES CORPORATION | 2025-01-23 | — | — | US | claimed |
| EP-4447667-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | United Industries Corporation (US) | 2024-10-23 | — | — | EP | claimed |
| US-12075781-B2 | Ready-to-use barrier and knockdown pesticides | UNITED INDUSTRIES CORPORATION (US) | 2024-09-03 | — | — | US | claimed |
| WO-2023115034-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | UNITED INDUSTRIES CORPORATION (US) | 2023-06-22 | — | — | WO | claimed |
| US-20230189812-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | ROYAL BANK OF CANADA (CA) | 2023-06-22 | — | — | US | claimed |
| US-20090163582-A1 | Stable Pesticide Concentrates and End-Use Emulsions | VALENT BIOSCIENCES CORPORATION | 2009-06-25 | — | — | US | claimed |
| EP-1865776-A1 | STABLE PESTICIDE CONCENTRATES AND END-USE EMULSIONS | Valent Biosciences Corporation (US) | 2007-12-19 | — | — | EP | claimed |
| WO-2006107905-A1 | STABLE PESTICIDE CONCENTRATES AND END-USE EMULSIONS | VALENT BIOSCIENCES CORPORATION (US) | 2006-10-12 | — | — | WO | claimed |
| US-3944666-A | Insecticidal compositions and methods of combatting insects using 3-phenoxybenzyl 2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropanecarboxylate insecticide with a synergistic compound of mono (alkyl and alkenyl)mono omega-alkynyl arylphosphonates | FMC CORPORATION (US) | 1976-03-16 | — | — | US | claimed |
| WO-2025030129-A2 | AEROSOL SPRAY DEVICE, INSECTICIDE COMPOSITION, AND METHOD OF USE | UNITED INDUSTRIES CORPORATION (US) | 2025-02-06 | — | — | WO | disclosed |
| US-20250024840-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | UNITED INDUSTRIES CORPORATION | 2025-01-23 | — | — | US | disclosed |
| EP-4447667-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | United Industries Corporation (US) | 2024-10-23 | — | — | EP | disclosed |
| US-12075781-B2 | Ready-to-use barrier and knockdown pesticides | UNITED INDUSTRIES CORPORATION (US) | 2024-09-03 | — | — | US | disclosed |
| CN-118450798-A | Ready-to-use barrier and knockdown pesticide | 联合工业公司 | 2024-08-06 | — | — | CN | disclosed |
| WO-2006107905-A1 | STABLE PESTICIDE CONCENTRATES AND END-USE EMULSIONS | VALENT BIOSCIENCES CORPORATION (US) | 2006-10-12 | — | — | WO | disclosed |
| EP-0976327-B1 | Tick controlling agent | SUMITOMO CHEMICAL CO (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-4713392-A | Pesticides | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1987-12-15 | — | — | US | disclosed |
| EP-0171249-A2 | Improvements relating to pesticides | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1986-02-12 | — | — | EP | disclosed |
| EP-0161921-A2 | Improvements relating to pesticides | BTG INTERNATIONAL LIMITED (GB) | 1985-11-21 | — | — | EP | disclosed |
| US-3944666-A | Insecticidal compositions and methods of combatting insects using 3-phenoxybenzyl 2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropanecarboxylate insecticide with a synergistic compound of mono (alkyl and alkenyl)mono omega-alkynyl arylphosphonates | FMC CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12075781-B2 | Ready-to-use barrier and knockdown pesticides | RTCB, MRTO4, DDT | MEN1 3424/4885KMT2A 3343/4885CA2 4451/4885 |
| US-20250024840-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | RTCB, MRTO4, DDT | MEN1 3424/4885KMT2A 3343/4885CA2 4451/4885 |
| US-20230189812-A1 | READY-TO-USE BARRIER AND KNOCKDOWN PESTICIDES | RTCB, MRTO4, DDT | MEN1 3424/4885KMT2A 3343/4885CA2 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.